Search
for
Sort by
Research 121–150 of 439
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS
- Androgen receptor: A promising therapeutic target in breast cancer
- Contraceptive use in acne
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- The endocrinology of baldness
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- PCOS: update and diagnostic approach
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Congenital adrenal hyperplasia
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- Polycystic Ovary Syndrome
- Acne vulgaris
- Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children
- The Evaluation and Management of Hirsutism
- Testosterone Therapy in Premenopausal Women
- The role of androgen therapy
- Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome
- Assessment of diagnostic competence of plasmatic androgens on polycystic ovary syndrome based on receiver operator characteristic curves
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- Clinical manifestations of polycystic ovary syndrome
- Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature
- Androgen receptor CAG repeat length is associated with ovarian reserve but not with ovarian response
- Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight